Reactive airways dysfunction syndrome following acute lithium hydroxide dust exposure at a battery material production plant: a case series of 16 workers Authors: Chul Gab Lee, Soo Hyeong Park, Jeong Joon Park, Han Soo Song, Hyeon Kyeong Ko, Sung Ho Yoon Published: 2026 ABSTRACT BackgroundReactive airways dysfunction syndrome (RADS) is an acute-onset form of irritant-induced asthma that occurs after a single high-concentration exposure to irritants. Although RADS has been documented for chlorine, ammonia, and acid fumes, no published case series has attributed RADS to lithium hydroxide (LiOH) dust inhalation. We report the clinical features, diagnostic evaluation, and longitudinal management of 16 workers with persistent respiratory symptoms following acute occupational LiOH exposure at a battery cathode material production facility. Case presentationIn March 2024, a silicone connector failure resulted in the leakage of approximately 50–100 kg of LiOH powder at a facility in Korea, exposing over 500 workers. Sixteen workers (15 men, 1 woman; mean age 53.4 years) with persistent respiratory symptoms were evaluated at the Department of Occupational and Environmental Medicine. Most patients presented with cough and sputum production; 56.3% (9/16) exhibited nocturnal or early-morning exacerbation. Methacholine challenge testing was performed in 10 patients, with positive results in three patients (PC20 [provocative concentration causing a 20% decline in forced expiratory volume in 1 second]: 1.36–6.74 mg/mL). By the Brooks 1985 criteria, one case was classified as definite RADS, four as probable, six as possible, and five as unlikely; American College of Chest Physicians 2008 cross-validation yielded identical classifications. Workers' compensation recipients had significantly longer follow-up (18–23 months) compared to non-recipients (1–3 months). Pharmacological management was symptom-directed, combining leukotriene receptor antagonists, mucolytics, antihistamines, and acid-suppressive therapy.Conclusions Acute high-concentration LiOH dust inhalation may induce RADS characterized by persistent respiratory symptoms and bronchial hyperresponsiveness. The extreme alkalinity, high water solubility, and exothermic dissolution of LiOH provide a plausible mechanistic framework for airway injury. Clinicians should consider RADS in workers presenting with persistent respiratory symptoms after alkaline dust exposure, even when routine investigations are unremarkable. Attention should also be given to the psychological burden associated with prolonged, poorly recognized symptoms. BACKGROUND The rapid expansion of the lithium-ion battery industry has increased the potential for occupational exposure to lithium hydroxide (LiOH), a highly alkaline compound. Exposure to substantial amounts of LiOH can result in localized respiratory symptoms, such as coughing and sputum production, as well as a variety of systemic symptoms, including headache, nausea, chest tightness, dizziness, and fatigue.1 Although the production processes for LiOH are primarily automated, workers engaged in raw material input, product packaging, and maintenance activities may experience dermatological symptoms, including itching, erythema, and chemical burns.2 In March 2024, during the commissioning of a new LiOH facility in Korea, a silicone connector within the powder supply line sustained damage due to mechanical vibrations. This incident resulted in a leakage of 50 to 100 kg of LiOH powder, impacting hundreds of workers. Reports documented acute health effects.1 Numerous workers exhibited chronic symptoms, including persistent cough, sore throat, foreign body sensation, and shortness of breath, persisting for over four weeks. Despite visits to hospitals in proximity to the factory, no definitive diagnosis or intervention was established, as chest X-rays and blood tests revealed no specific abnormalities. Some workers were suspected of symptom exaggeration or malingering. Consequently, a subset of workers was referred to the occupational and environmental medicine (OEM) outpatient clinic through the Occupational Disease Surveillance Center of Korea (KODSC). Upon clinical assessment, it was determined that the symptoms in these patients were consistent with reactive airways dysfunction syndrome (RADS), a distinct form of irritant-induced asthma (IIA) first described by Brooks et al. in 1985.3 RADS is characterized by acute asthma-like symptoms after a single high-concentration exposure to irritating vapors, fumes, or dust, without pre-existing respiratory disease, with nonspecific bronchial hyperresponsiveness (BHR) persisting for months to years.3,4 Although RADS has been documented following exposure to chlorine, ammonia, sulfur dioxide, and various acid fumes, there is no published case series specifically associating RADS with LiOH dust inhalation.5,6 The original RADS concept from 1985 involved 10 healthy individuals developing persistent asthma-like symptoms after a single high-concentration irritant exposure,3 and has since evolved. Subsequent observations that did not conform to the single-massive-exposure model led to identifying “low-dose RADS”7 and distinctions between “sudden-onset” and “not-so-sudden-onset” forms resulting from repeated sub-massive exposures.8 The 2008 American College of Chest Physicians (ACCP) criteria reduced the original eight items to six by removing the requirement for symptom persistence of ≥3 months and allowing for the absence of demonstrable airflow obstruction,4 while the 2019 Brooks refinement reinstated a positive methacholine challenge with PC20 (provocative concentration causing a 20% decline in forced expiratory volume in 1 second [FEV1]) < 8 mg/mL as a critical diagnostic criterion.9 RADS is now encompassed within the broader IIA framework,10-13 and the term “acute IIA” is increasingly used to reflect this unified framework. This report examines the clinical characteristics of 16 workers who experienced persistent respiratory symptoms following acute occupational exposure to LiOH. This exposure pattern is consistent with acute-onset IIA (classic RADS) resulting from a single high-concentration exposure,13 according to Brooks’ 1985 criteria.3 The study aims to enhance the understanding of LiOH as a potential causative agent of airway dysfunction induced by irritants. CASE PRESENTATION Study design and subjects This retrospective case series included 16 workers (15 men, 1 woman) who attended the OEM outpatient clinic of a tertiary university hospital approximately 100 km from the exposure site, between April and August 2024. Initial visits occurred about four weeks after the accident on March 6, 2024, in which over 500 workers were exposed to aerosolized LiOH dust during the construction and trial operation of a battery cathode material facility. Details of the accident and the immediate symptom profile of the broader exposed population (n = 474) have been reported previously.1 The 16 patients in this series represent a subgroup with refractory respiratory symptoms despite normal chest radiography and laboratory tests at primary care; their selection pathway is shown in Fig. 1. Demographic characteristics, occupational roles, and follow-up information are summarized in Table 1. Outpatient visits ranged from 3 (cases B, C, K, M, N, O, and P) to 46 (case H), and follow-up duration from the accident (March 6 and 9, 2024) to the final visit ranged from 1 to 23 months (median 3 months). Patients approved for workers' compensation (WC) were generally followed for 18–23 months, whereas those who did not apply—often because of job insecurity such as contract non-renewal or loss of further opportunities—were followed for only 1–3 months. Symptom profiles and diagnostic tests Symptom profiles and clinical trajectories of all 16 patients are summarized in Table 2, organized into six domains: acute symptoms occurring within 24 hours after exposure, respiratory, upper airway, dermatological, ocular, and systemic complaints. Most patients experienced symptoms including cough, sputum production, and dyspnea, with nine cases (56.3%) reporting exacerbations occurring at night or in the early morning. The ongoing nature of these respiratory symptoms was the main reason for seeking consultations in the Department of Occupational and Environmental Medicine (OEMD). The most common clinical trajectory was “partial resolution with residual symptoms.” Six patients (cases A, D, E, F, G, and H) had persistent symptoms for 18–24 months with fluctuating exacerbation and remission, whereas four patients (cases M, N, O, and P) discontinued follow-up after symptom improvement. Case L developed a postexposure pulmonary embolism that transiently improved with hyperbaric oxygen therapy before re-exacerbating; its relationship to LiOH exposure remains uncertain. Pulmonary function tests (PFT), methacholine challenge, fractional exhaled nitric oxide (FeNO), and high-resolution computed tomography (HRCT) findings are detailed in Table 3; all spirometric values are post-bronchodilator. Reduced FEV₁ (<80% predicted), FEV₁/forced vital capacity (FVC) <70%, lower FEF25–75% (forced expiratory flow at 25–75% of FVC), decreased diffusing capacity of the lung for carbon monoxide (<75%), and elevated airway resistance (Raw >1.5 cmH₂O/L/s) were identified in several cases (Table 3). No case met the conventional FEV₁ reversibility threshold (≥12% and ≥200 mL), but four patients (cases G, H, N, and O) showed FEF25–75% reversibility ≥25%, suggesting small airway reversibility. The methacholine challenge test (MCT) was performed in 10 patients; three were positive—case A (PC20 5.08 mg/mL, moderate BHR), case B (1.36 mg/mL, moderate–severe BHR), and case C (6.74 mg/mL, mild BHR)—while the remaining seven had PC20 >16 mg/mL. MCT was not performed in six patients (cases D, K, M, N, O, and P) who did not consent or did not apply for WC. FeNO was within the normal range (<25 ppb) in all four patients tested. HRCT findings were heterogeneous: subpleural nodules were the most common abnormality (cases A, F, J, L, O, and P); ground-glass opacities appeared in cases E, M, and N; case B showed interstitial lung disease with a usual interstitial pneumonia (UIP) pattern; and case D showed bronchopneumonia/bronchiolitis. Paranasal sinus radiographs in eight patients with nasal fullness were unremarkable. RADS diagnostic criteria evaluation Three RADS diagnostic frameworks were applied: the original Brooks 1985 eight criteria,3 the 2008 ACCP streamlined criteria,4 and the Brooks 2019 refined criteria, which emphasize a positive MCT with PC20 <8 mg/mL.9 Detailed criterion definitions and the coding scheme used (O = met, △ = partially met or borderline, X = not met) are provided in the footnote of Table 4. By the Brooks 1985 criteria, the cohort was classified as one definite case (case A), four probable (cases B, C, D, and E), six possible (cases F, G, H, I, J, and K), and five unlikely (cases L, M, N, O, and P) (Table 4). Criterion C1 (absence of prior respiratory disease) was satisfied in all 16 patients, whereas C6 (airflow limitation) and C7 (BHR) were most frequently unmet—reflecting both the known tendency of RADS to present with normal routine spirometry and the fact that MCT could not be performed in seven patients. Application of the 2008 ACCP criteria yielded identical classifications because the principal limiting factors in this cohort were MCT availability and exposure documentation rather than symptom duration or airflow obstruction. By the Brooks 2019 refined criteria, cases A, B, and C satisfied the PC20 <8 mg/mL threshold. Ethics statement This study was conducted in accordance with the ethical principles of the Declaration of Helsinki. The study protocol was reviewed and approved by the Institutional Review Board of Chosun University Hospital (approval No. CHOSUN 2025-08-011). Written informed consent was obtained from all participants prior to enrollment. DISCUSSION AND CONCLUSION Diagnostic framework rationale The general definition of asthma describes a heterogeneous chronic respiratory disease characterized by variable respiratory symptoms and variable expiratory airflow, usually associated with chronic airway inflammation.14 IIA is an etiologic and work-related phenotype of asthma in which new-onset asthma is attributed to inhalational exposure to respiratory irritants, typically in the absence of immunologic sensitization.13,15,16 The Brooks 1985 criteria3 were employed as the primary diagnostic framework throughout this study, because it remains the most widely cited and clinically applicable framework of RADS, and it most accurately aligns with the single-massive-exposure scenario observed in this cohort. The 2008 ACCP criteria4 and the Brooks 2019 refinement9 were used as cross-validation tools rather than parallel classifiers. The broader concept of acute IIA10-13,15,16 is mentioned here only as a concept encompassing the mechanistic interpretation and is not used as a separate diagnostic criterion. Selection pathway and clinical heterogeneity The 16 cases reported here were not a random sample of the more than 500 workers acutely exposed to LiOH dust.1 As shown in Fig. 1, among workers who received an initial evaluation at a primary care facility, those whose symptoms persisted despite the absence of specific findings in chest X-rays and general blood tests were referred via KODSC to the OEMD of a university hospital located 100 km away. This pathway induces selection bias in two opposing directions. This referral pathway introduces substantial selection bias. Because only workers with persistent or refractory symptoms were referred to tertiary care, symptom severity may have been overrepresented in this cohort. Conversely, because only 16 out of over 500 exposed workers were ultimately evaluated, it is also highly likely that the actual incidence of LiOH-induced RADS was significantly underestimated. Recognizing both directions of bias is essential when interpreting both severity and prevalence. The clinical heterogeneity observed across the 16 cases—from definite RADS to symptom complexes meeting only some Brooks 1985 criteria3—is consistent with the spectrum-of-disease view of irritant-induced airway disorders.10 In case B, HRCT revealed findings consistent with a UIP pattern of interstitial lung disease (ILD), alongside a positive MCT (PC20 1.36 mg/mL). The UIP pattern of ILD is characterized as a chronic and progressive fibrotic process, making it unlikely that a single LiOH exposure alone caused the fibrotic process. It is plausible, however, that subclinical ILD existed prior to the exposure, and that BHR and interstitial changes were exacerbated following the alkaline injury. Nevertheless, due to the absence of imaging data prior to the exposure, this hypothesis cannot be conclusively validated.17 Reasons for MCT non-performance and its diagnostic consequences MCT was not performed in seven of the 16 patients (cases D, I, K, M, N, O, and P) due to varied reasons. Cases D, M, N, O, and P opted out of MCT during clinical consultations, citing concerns related to cost, anticipated discomfort, or the tolerability of their symptoms. Case K was unable to attend the scheduled MCT appointment. Notably, the absence of MCT does not directly correlate with WC status: although eight individuals (cases B, C, K, L, M, N, O, and P) did not apply for WC, three of them (cases B, C, and L) still underwent MCT. This discrepancy suggests that the decision to proceed with MCT was influenced more by individual willingness, symptom persistence, and the duration of clinical follow-up rather than by compensation status. Given that MCT is integral to the Brooks 1985 and Brooks 2019 criteria,3,9 the lack of MCT data limits the application of RADS classification in these seven cases and contributes to the underdiagnosis observed in this cohort. WC eligibility and follow-up period The WC status detailed in Table 1 was not pursued by some individuals due to concerns about potential contract renewal denial or unemployment, as well as a lack of understanding of the administrative procedures or apprehensions regarding the approval of their applications. Nevertheless, given that the incident was publicly reported and acknowledged as a factual occurrence, all submitted applications were approved. As a result, the decision to apply for WC influenced the duration of the follow-up period, which ranged from 1 to 3 months for those who did not apply, compared to 18 to 23 months for those whose applications were approved. This discrepancy also affected the likelihood of undergoing MCT tests or repeated PFT, thereby hindering the ability to ascertain differences in the clinical course. Physicochemical hypothesis for LiOH-induced airway injury Among agents implicated in acute IIA or RADS, substances with extreme pH constitute a prominent etiological category. Both strong acids and strong alkalis (e.g., ammonia, calcium oxide, and hydrazine) are established causes of acute IIA,13 and a systematic review of RADS cases has identified strong acidic and alkaline agents—including sodium hydroxide and sulfuric acid—among the implicated exposures.5 These observations suggest that pH-driven chemical reactivity is a critical determinant of RADS induction. The mechanism by which pH extremes injure the respiratory epithelium differs fundamentally between acids and alkalis. Acidic exposures typically cause coagulative necrosis, a self-limiting surface injury in which protein precipitation forms an eschar that retards further tissue penetration.18,19 Alkaline dusts such as cement, concrete, and calcium oxide instead induce liquefactive necrosis through protein denaturation and lipid saponification, allowing progressive penetration into deeper respiratory tissues, with epithelial sloughing, impaired mucociliary clearance, and diffuse neutrophilic inflammation.20-22 Cement-derived particles release tumor necrosis factor-α from alveolar macrophages in proportion to their CaO content, with concomitant oxidative stress and pro-inflammatory cytokine production.20,21 Although both classes generate reactive oxygen species, alkaline injury is more closely associated with structural damage extending into the subepithelial layers, whereas acidic injury tends to remain confined to the airway surface.20,23,24 Lithium hydroxide possesses a combination of physicochemical properties that may render it an exceptionally potent alkaline airway irritant. The airway surface liquid (ASL) is estimated at approximately 3–4 mL at rest and up to 20 mL under inflammatory conditions.25 LiOH dust (molecular weight 23.95 g/mol) is highly water-soluble (12.8 g/100 mL) and strongly hygroscopic;26 on contact with the warm, fully humidified airway surface, it would be expected to dissolve almost instantaneously. Even a modest 1 g inhaled dose (≈ 0.042 mol) dissolving within ~10 mL of ASL could theoretically yield a hydroxide ion concentration of about 4.18 mol/L, corresponding to a pH far beyond the physiological measurement scale.27 The bicarbonate-based ASL buffering system, which maintains airway pH within 6.8–7.4, would likely be overwhelmed within seconds.28 The consequences of extreme alkalinization likely follow the alkali-specific injury pathway described above. Hydroxide ions released by dissolved LiOH may continuously saponify membrane phospholipids and hydrolyze structural proteins.20 The absence of a self-limiting eschar would allow alkaline injury to propagate into the subepithelial layers, disrupt mucociliary architecture, and trigger diffuse neutrophilic inflammation at depths unreachable by acidic exposures of comparable concentration.20,21 The exothermic dissolution of LiOH (ΔHsol ≈ −23.5 kJ/mol) imposes a thermal insult that compounds the chemical injury.29 Together, these three converging mechanisms—extreme alkalinity, progressive liquefactive penetration without eschar-mediated self-limitation, and concurrent exothermic thermal injury—provide a plausible physicochemical basis for the persistent airway inflammation and BHR observed in this cohort. Clinical implications The most important practical lesson of this report is not whether cases of symptom complaints after the accident can be diagnosed with RADS but rather how to manage them. After the LiOH leak, more than 500 workers were exposed;1 only 16 ultimately reached an OEM clinic capable of structured RADS evaluation. This recognition gap reflects a recurring pattern at primary care: when patients describe persistent cough, sputum, throat irritation, or exertional dyspnea after a documented chemical accident—but their chest radiograph is unremarkable and routine blood tests are normal—the absence of objective radiographic abnormalities may contribute to under-recognition of irritant-induced airway disease. The pattern is reinforced when patients also pursue WC, because primary care physicians and the consulting physicians who advise the Korea Workers’ Compensation Service (KCOMWEL) tend to equate the absence of a radiologically demonstrable lesion with the absence of disease. Within the framework of Brooks’ 1985 definition3 and the broader IIA concept10-12, RADS can exhibit persistent BHR without any imaging abnormalities. While the MCT, an essential diagnostic procedure for RADS, is not typically available in primary care environments, this limitation should not be misinterpreted as evidence of the disease’s nonexistence. Pharmacological management in this cohort was predominantly symptom-directed rather than disease-modifying. The four drug classes most consistently prescribed were leukotriene receptor antagonists (montelukast) for cough hypersensitivity, mucolytics and expectorants for productive cough, second-generation H1 antihistamines for upper-airway and nasal symptoms,29 and acid-suppressive therapy (proton pump inhibitors, potassium-competitive acid blockers, or H2 receptor antagonists) for reflux laryngitis as an aggravating factor.30 This combination—rather than a single asthma controller—was the backbone of long-term care for most patients, particularly those in whom methacholine challenge was negative or unavailable. Case A, who returned to his pre-exposure duties early, eventually required inhaled triple therapy (inhaled corticosteroid + long-acting beta2-agonist + long-acting muscarinic antagonist) and short oral corticosteroid courses;14 Case G, with a negative methacholine challenge but heightened cough reactivity to minor stimuli, required only intermittent oral corticosteroids—illustrating that a negative challenge does not exclude clinically significant irritant-induced airway dysfunction.10 Beyond pharmacotherapy, long-term care required attention to a dimension rarely emphasized in the RADS literature: the psychological burden of an unrecognized, contested illness, which in some workers extended to clinically meaningful post-traumatic stress symptoms attributable to the accident itself. Workplace chemical accidents—particularly those involving perceived life-threat, a confined work team, and prolonged uncertainty about diagnosis or compensation—are a recognized precipitant of work-related post-traumatic stress disorder.31 Many patients arrived at the OEM clinic having been suspected of exaggeration, compensation-seeking behavior, or malingering—a contested-illness experience that itself amplifies post-traumatic symptoms by undermining validation and recovery.32 Sustained follow-up, therefore, included not only respiratory management but also screening for trauma-related distress (intrusive recollections of the leak event, hyperarousal, workplace avoidance), structured listening, validation of symptoms, and a clear pathophysiological explanation of why a single high-concentration alkaline dust exposure can produce months of airway hyperreactivity despite normal chest imaging—which appeared to improve treatment adherence and reduce anxiety in some patients. OEM physicians are uniquely positioned to recognize and address this dual physical–psychological burden, combining as they do knowledge of the exposure event, the work environment, the compensation system, and the longitudinal clinical course. However, low accessibility to specialized testing and familiarity with RADS/IIA may contribute to delayed recognition and management. Furthermore, residual BHR exposes these patients to recurrent symptomatic exacerbation by even sub-irritant levels of the same agent,11,12 and no firm pulmonary-function or hyperresponsiveness threshold for safe return-to-work has been established. This report presents the first documented case of RADS induced by LiOH. We underscore the importance of recognizing that persistent respiratory symptoms following exposure may indicate irritant-induced airway disease, even when general diagnostic test results appear normal. Furthermore, we contend that the management of such conditions necessitates a comprehensive approach that integrates medical treatment, psychological considerations (including trauma), and occupational factors. The decision to resume work should not rely solely on chest imaging or general blood test results. Limitations Several limitations of this study warrant consideration. First, the retrospective, single-center, observational design precludes the establishment of a definitive causal relationship between LiOH exposure and RADS. The absence of quantitative airborne LiOH concentration data is a notable limitation; however, this reflects the accidental nature of the exposure event, during which industrial hygiene monitoring was not in place. The theoretical pH calculations presented in the Discussion, while consistent with established alkaline injury mechanisms, remain unvalidated by in vivo measurements and should be interpreted as a mechanistic framework rather than a precise quantitative estimate. Second, the cohort of 16 patients represents a highly selected subset of the more than 500 workers exposed during the accident. Selection bias is inherent, as these patients were referred to a university hospital 100 km from the exposure site specifically because of persistent and refractory symptoms, and thus are not representative of the full spectrum of LiOH-induced respiratory effects. Milder or self-limiting cases were likely not captured in this series. Third, MCT—central to definitive RADS diagnosis—was not performed in six of 16 patients (37.5%). The reasons for non-performance included: patients who did not apply for WC had no clinical or administrative requirement for objective BHR documentation; employment insecurity discouraged prolonged medical evaluation; and the cost of MCT represented a barrier for uncompensated patients. This limitation directly affects the reliability of RADS classification in these cases and likely results in underdiagnosis. Fourth, differential follow-up duration constitutes a significant source of potential bias. WC recipients were followed for 18–23 months, whereas non-recipients were observed for only 1–3 months. This disparity may systematically underestimate symptom persistence and disease progression in non-recipients. Fifth, several patients had potential confounders, including smoking history (cases K and M) and pre-existing conditions (chronic rhinosinusitis in case I, rheumatoid arthritis in case N), which may independently contribute to respiratory symptoms and complicate attribution to LiOH exposure. Finally, the absence of pre-exposure baseline PFT data for any patient prevents quantification of post-exposure functional decline. Despite these limitations, this report provides the first systematic clinical characterization of RADS, classified as a subtype of occupational asthma that occurs after occupational exposure to LiOH dust. Conclusion This case series demonstrates that acute high-concentration inhalation exposure to LiOH dust, a strong alkaline irritant, may be associated with RADS-like illness characterized by persistent respiratory symptoms, bronchial hyperresponsiveness, and a prolonged fluctuating clinical course. Clinicians evaluating workers with persistent nonspecific respiratory complaints following exposure to alkaline dust or other high-concentration irritants should consider RADS in the differential diagnosis, even when routine imaging and laboratory investigations are unremarkable. With the expanding lithium-ion battery industry, awareness of the respiratory hazards of lithium compounds, including the potential for RADS, is of increasing occupational health importance.